BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9301549)

  • 1. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.
    Rosa JC; Félix A; Fonseca I; Soares J
    J Clin Pathol; 1997 Aug; 50(8):661-3. PubMed ID: 9301549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of different keratins in salivary gland tumours.
    de Araújo VC; de Sousa SO
    Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):14-8. PubMed ID: 8729613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vimentin as a marker of myoepithelial cells in salivary gland tumors.
    de Araújo VC; de Araújo NS
    Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours.
    Kamio N
    Virchows Arch; 1996 May; 428(2):75-83. PubMed ID: 8925128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics.
    Gorski Z; Purgina B; Wasserman JK
    Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases.
    Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S
    Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoepithelial differentiation markers in salivary gland neoplasia].
    Scarpellini F; Marucci G; Foschini MP
    Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands.
    Vékony H; Röser K; Löning T; Raaphorst FM; Leemans CR; Van der Waal I; Bloemena E
    Histopathology; 2008 Dec; 53(6):658-66. PubMed ID: 19076682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
    de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
    Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of c-erbB-2 oncogene and mutation of p53 gene in myoepithelioma and myoepithelial carcinoma].
    Wang J; Dong F; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):71-3. PubMed ID: 9387534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
    Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morphological spectrum of salivary gland type tumours of the breast.
    Foschini MP; Morandi L; Asioli S; Giove G; Corradini AG; Eusebi V
    Pathology; 2017 Feb; 49(2):215-227. PubMed ID: 28043647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin expression in carcinoma ex pleomorphic adenoma.
    Martins MT; Altemani A; Freitas L; Araújo VC
    J Clin Pathol; 2005 Dec; 58(12):1311-4. PubMed ID: 16311353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
    Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.